Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.
Company profile
Website
CEO
Terrence W. Norchi
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
204425710
Latest ownership filings
No filings